Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$Allarity Therapeutics (ALLR.US)$ offering :   At-The-Marke...

At-The-Market Issuance Sales Agreement

This First Comprehensive Amendment to At-The-Market Issuance Sales Agreement (this “Amendment”) is entered into on May 17, 2024 (the “Effective Date”) by and between Ascendiant Capital Markets, LLC (the “Agent”), and Allarity Therapeutics, Inc., a Delaware corporation (the “Company”). Defined terms used herein have the definitions assigned to them in the At-The-Market Issuance Sales Agreement between the parties dated March 19, 2024 (the “Sales Agreement”). Unless specifically amended or modified herein, the other terms of the Sales Agreement remain in full force and effect, not amended or modified, as of the date hereof.

1. The parties have entered into several verbal amendments to the Sales Agreement, each resulting in increases in the amount of Placement Shares that may be sold thereunder. The parties desire to comprehensively document the amendments as set forth herein.

2. The amount of Placement Shares that may be sold under and pursuant to the terms of the Sales Agreement is increased to $30,000,000.

3. Other than as set forth herein, the terms and conditions of the Sales Agreement shall remain in full force and effect.

If the foregoing correctly sets forth the understanding between the Company and the Agent, please so indicate in the space provided below for that purpose, whereupon this letter will constitute a binding agreement between the Company and the Agent.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
9667 Views
Comment
Sign in to post a comment
    Human Collector - Planet Earth - Relationships are a Currency - 👽 - I Speak Money - Volatile - Unpredictable -
    70Followers
    55Following
    473Visitors
    Follow